Showing 1,401 - 1,420 results of 1,516 for search '"breast cancer"', query time: 0.13s Refine Results
  1. 1401

    Nutritional Counseling During Chemotherapy Treatment: A Systematic Review of Feasibility, Safety, and Efficacy by Shalet James, Alexie Oppermann, Kaitlin M. Schotz, Mackenzie M. Minotti, Gautam G. Rao, Ian R. Kleckner, Brenton J. Baguley, Amber S. Kleckner

    Published 2024-12-01
    “…One-third (31%) were among patients with breast cancer. Interventions were divided into individualized nutritional counseling (<i>n</i> = 21), nutrition counseling plus exercise (<i>n</i> = 13), and nutrient-specific dietary patterns (<i>n</i> = 10). …”
    Get full text
    Article
  2. 1402

    Cytotoxic Constituents from the Rhizomes of Curcuma zedoaria by Omer Abdalla Ahmed Hamdi, Syarifah Nur Syed Abdul Rahman, Khalijah Awang, Norhanom Abdul Wahab, Chung Yeng Looi, Noel Francis Thomas, Sri Nurestri Abd Malek

    Published 2014-01-01
    “…Thus, the present study provides basis for the ethnomedical application of Curcuma zedoaria in the treatment of breast cancer.…”
    Get full text
    Article
  3. 1403

    Medium Time Heating of Syrop from Red Betel Leaf (Piper crocatum ruiz pav) Can Reduce Carcinoembryonic Antigen (CEA) Level Among Adult Women in Southeast Sulawesi, Indonesia by Hariani Hariani, Wiralis Wiralis, Teguh Faturrahman Teguh Faturrahman, Suwarni Suwarni

    Published 2025-01-01
    “…Red betel leaves have been shown to induce apoptosis in breast cancer cells (MCF-7), activate pro-apoptotic proteins (Bax), and inhibit anti-apoptotic proteins (Bcl-2). …”
    Get full text
    Article
  4. 1404

    CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) (REVIEW) by N. I. Rozhkova, I. I. Burdina, S. B. Zapirova, M. L. Mazo, S. P. Prokopenko, O. E. Yakobs

    Published 2016-01-01
    “…The problem of early diagnosis of a breast cancer is extremely actual. Growth of incidence at women from 19 to 39 years increased for 34% over the last 10 years. …”
    Get full text
    Article
  5. 1405

    Association of Fatty Acid Synthase with Level of Fatty Acids in Osteoporosis Patients by Abeer Hassan Alwan, Ekhlass M. Taha

    Published 2025-01-01
    “…Osteoporotic fractures are more common in women than breast cancer, myocardial infarction, or stroke, and they also incur higher hospital treatment costs. …”
    Get full text
    Article
  6. 1406

    Melanoma Development and Progression Are Associated with Rad6 Upregulation and β-Catenin Relocation to the Cell Membrane by Karli Rosner, Darius R. Mehregan, Evangelia Kirou, Judith Abrams, Seongho Kim, Michelle Campbell, Jillian Frieder, Kelsey Lawrence, Brittany Haynes, Malathy P. V. Shekhar

    Published 2014-01-01
    “…We have previously demonstrated that Rad6 and β-catenin enhance each other's expression through a positive feedback loop to promote breast cancer development/progression. While β-catenin has been implicated in melanoma pathogenesis, Rad6 function has not been investigated. …”
    Get full text
    Article
  7. 1407

    HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast by Katsumi Kito, Toshiharu Maeda, Keiko Ninomiya, Atsuro Sugita, Teiri Sagawa, Kinya Matsuoka, Kousei Kinoshita, Naoki Hyodo, Nagisa Morita, Keizo Furuya

    Published 2014-01-01
    “…Apocrine carcinoma, which is strictly defined as over 90% of tumor cells showing apocrine differentiation, is a rare variant of breast cancer. Here we report an uncommon case in which apocrine carcinomas developed concurrently in both breasts; in addition, a sarcomatoid spindle cell lesion was coincident in the right breast. …”
    Get full text
    Article
  8. 1408

    The COVID‐19 pandemic and associated declines in cancer incidence by race/ethnicity and census‐tract level SES, rurality, and persistent poverty status by Benmei Liu, Mandi Yu, Jeffrey Byrne, Katheen A. Cronin, Eric J. Feuer

    Published 2024-09-01
    “…Significantly larger PCs were observed for the lowest versus highest SES groups (prostate cancer), PP versus non‐PP groups (prostate and female breast cancer), and all urban versus rural areas (prostate, female breast, female and male lung, colon, cervix, melanoma, liver, bladder, and kidney cancer). …”
    Get full text
    Article
  9. 1409

    Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England by Jo Waller, Rumana Newlands, Lauren Gatting, Angie A Kehagia, Syeda Ahmed, Priscilla Meccheri

    Published 2024-12-01
    “…Introduction Preliminary studies of artificial intelligence (AI) tools developed to support breast screening demonstrate the potential to reduce radiologist burden and improve cancer detection which could lead to improved breast cancer outcomes. This study explores the public acceptability of the use of AI in breast screening from the perspective of screening-eligible women in England.Methods 64 women in England, aged 50–70 years (eligible for breast screening) and 45–49 years (approaching eligibility), participated in 12 focus groups—8 online and 4 in person. …”
    Get full text
    Article
  10. 1410

    Proteome-Wide Identification and Comparison of Drug Pockets for Discovering New Drug Indications and Side Effects by Renxin Zhang, Zhiyuan Chen, Shuhan Li, Haohao Lv, Jinjun Li, Naixue Yang, Shaoxing Dai

    Published 2025-01-01
    “…We repositioned progesterone to ADGRD1 for pemphigus and breast cancer, as well as estradiol to ANO2 for shingles and medulloblastoma, which were validated via molecular docking. …”
    Get full text
    Article
  11. 1411

    Clinical Characteristics and Prognosis of Gastrointestinal Metastases in Solid Tumor Patients: A Retrospective Study and Review of Literatures by Li Lin, Xiangyi Wang, Chuanhao Tang, Jun Liang

    Published 2019-01-01
    “…Ten patients (33.3%) underwent local gastrointestinal treatment, and 20 patients (66.7%) underwent nonlocal treatment (involving chemotherapy alone or best supportive care). For breast cancer patients and gastric cancer patients who underwent local therapy, a significant survival advantage was observed (p=0.001 and p=0.012, respectively). …”
    Get full text
    Article
  12. 1412

    Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration by Qian Du, Jiaojiao Xu, Miao Zhang, Jianhong Yang

    Published 2025-03-01
    “…Triple-negative breast cancer (TNBC) is an exceptionally aggressive malignancy with poor prognosis. …”
    Get full text
    Article
  13. 1413

    Bibliometric analysis of rhein in the treatment of tumors by Lan Jiang, Lan Jiang, Lan Jiang, Qian Huang, Zhongquan Shi, Yi Yang

    Published 2025-02-01
    “…It has inhibitory effects on liver cancer, breast cancer, lung cancer, oral cancer, gastric cancer, and other cancers. …”
    Get full text
    Article
  14. 1414

    Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice by Dai Fukumura, Rakesh K Jain, Jun Ren, Xinyue Dong, Zohreh Amoozgar, Somin Lee, Meenal Datta, Sylvie Roberge, Mark Duquette

    Published 2023-03-01
    “…Moreover, we demonstrated that vascular normalization can improve the delivery of CD8+ T cells and the efficacy of immunotherapy in breast cancer models in mice. In fact, the US FDA (Food and drug administration) has approved seven different combinations of anti-VEGF drugs and immune checkpoint blockers for liver, kidney, lung and endometrial cancers in the past 3 years. …”
    Get full text
    Article
  15. 1415

    The Effect of Nutritional Mobile Apps on Populations With Cancer: Systematic Review by Krystal Lu Shin Ng, Murallitharan Munisamy, Joanne Bee Yin Lim, Mustafa Alshagga

    Published 2025-02-01
    “…Most studies focused on breast cancer (6/13, 46%), overweight (6/13, 46%), and survivors (9/13, 69%). …”
    Get full text
    Article
  16. 1416

    Pegylated NIR Fluorophore-Conjugated OBHSA Prodrug for ERα-Targeted Theranostics with Enhanced Imaging and Long-Term Retention by Xiaohua Wang, Xiaofei Deng, Lilan Xin, Chune Dong, Guoyuan Hu, Hai-Bing Zhou

    Published 2025-01-01
    “…OBHSA-PEG-DCM holds promise as a theranostic agent for ERα-positive breast cancer, offering both therapeutic and diagnostic capabilities. …”
    Get full text
    Article
  17. 1417

    Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma by Heike Loeser, Max Kraemer, Florian Gebauer, Christiane Bruns, Wolfgang Schröder, Thomas Zander, Hakan Alakus, Arnulf Hoelscher, Reinhard Buettner, Philipp Lohneis, Alexander Quaas

    Published 2020-01-01
    “…IDO is known as a poor prognostic marker in esophageal squamous cell cancer, while a positive effect was shown for breast cancer. A comprehensive analysis of IDO expression in a well-defined cohort of esophageal adenocarcinoma (EAC) is missing. …”
    Get full text
    Article
  18. 1418

    Concurrent Viewing of H&E and Multiplex Immunohistochemistry in Clinical Specimens by Larry E. Morrison, Tania M. Larrinaga, Brian D. Kelly, Mark R. Lefever, Rachel C. Beck, Daniel R. Bauer

    Published 2025-01-01
    “…<b>Results:</b> Application is made to several clinically relevant specimens, including breast cancer (HER2, ER, and PR), prostate cancer (PSMA, P504S, basal cell, and CD8), Hodgkin’s lymphoma (CD15 and CD30), and melanoma (LAG3). …”
    Get full text
    Article
  19. 1419

    Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node by Yu Xia, Yu Huang, Zheng Liu, Siyuan Song, Yi Wang, Yi Wang, Jing Luo

    Published 2025-01-01
    “…To unravel the carcinogenesis, the next-generation sequencing (NGS) was performed.ResultsConventional examinations and imaging suggested the presence of both occult breast cancer and ovarian cancer. However, immunohistochemical staining confirmed the diagnosis of high-grade serous ovarian carcinoma. …”
    Get full text
    Article
  20. 1420

    Inhibition of cancer cells using target-specific 2A3 antibody-conjugated gold nanoclusters by Jui-Chi Kuo, Tsung-Rong Kuo, Fajar Rinawati, Erna Susilowati, Sucipto, Dyah Ika Krisnawati

    Published 2022-03-01
    “…The cell viability assay indicated that 2A3-AuNCs could inhibit the growths of cancer cells with overexpressed CEACAM6, including breast cancer MDA-MB-231 and MDA-MB-468 cells. The fluorescence imaging results also demonstrated that 2A3-AuNCs could inhibit the growth of cancer cells with MDA-MB-231 and MDA-MB-468 cells. …”
    Get full text
    Article